|
Match
|
Document |
Document Title |
|
|
US20090291128 |
TRANSDERMAL DELIVERY OF CANNABINOIDS
The present invention overcomes the problems associated with existing drug delivery systems by delivering cannabinoids transdermally. Preferably, the cannabinoids are delivered via an occlusive...
|
|
|
US20090291127 |
TRANSDERMAL ANTI-DEMENTIA ACTIVE AGENT FORMULATIONS AND METHODS FOR USING THE SAME
A transdermal antidementia active agent formulation is provided. In certain embodiments, the formulation includes a backing, an active agent reservoir layer including an antidementia active agent,...
|
|
|
US20090291126 |
ADHESIVE PHARMACEUTICAL PREPARATION CONTAINING BISOPROLOL
An adhesive pharmaceutical preparation which has a less irritation to the skin surface, keeps excellent stability of bisoprolol in the preparation, and allows continuous administration of a...
|
|
|
US20090291120 |
Hydrophilic Polyurethane Compositions
A water-swellable linear polymer is made by reacting together a polyethylene oxide of number average molecular weight less than 4,000, an aliphatic diol, and a difunctional diisocyanate. Controlled...
|
|
|
US20090287228 |
Inorganic-organic melt-extruded hybrid yarns and fibrous composite medical devices thereof
Composite fibrous constructs are made of combinations of inorganic-organic hybrid monofilament or multifilament yarns containing at least 6 weight percent of inorganic micro-/nanoparticles and...
|
|
|
US20090264806 |
TRANSDERMAL DRUG ADMINISTRATION DEVICE
The present invention provides a transdermal drug administration device capable of freely controlling release of the drug. The transdermal drug administration device of the present invention...
|
|
|
US20090258063 |
Transdermal patch
The present invention provides a transdermal patch having excellent preservation stability and transdermal absorbency of DMAEs. The patch has a support and a plaster layer integrally laminated on...
|
|
|
US20090258062 |
Transdermal Therapeutic System Comprising Active Ingredient Particles and Having Increased Active Ingredient Flux
The invention relates to a transdermal therapeutic system, preferably a transdermal patch, having an active ingredient-containing matrix formed substantially of a water-insoluble base material,...
|
|
|
US20090258061 |
ONCE-A-DAY REPLACEMENT TRANSDERMAL ADMINISTRATION OF FENTANYL
A method and a daily replacement patch for transdermally administering an opioid for analgesic effect. The patch is applied to a subject to deliver the opioid through the skin. The patch may be...
|
|
|
US20090246266 |
PREPARATION AND COMPOSITION OF MELOXICAM TRANSDERMAL DRUG DELIVERY SYSTEM
A composition for transdermal permeation and a preparation method are disclosed. The composition including meloxicam as an active ingredient and further including at least one permeation enhancing...
|
|
|
US20090246265 |
ABUSE DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS
Described herein are compositions comprising opioids, opioid antagonists and prodrugs of the same, formulations comprising opioids, opioid antagonists and prodrugs of the same, and methods of using...
|
|
|
US20090246264 |
Transdermal Tobacco Alkaloid Patch
The invention relates to a tobacco alkaloid patch ( 10; 41; 42; 43; 51; 52; 53; 54 ) for transdermal administration of a tobacco alkaloid, said patch comprising an impermeable backing ( 11 ) and a...
|
|
|
US20090238861 |
FENTANYL SUSPENSION-BASED SILICONE ADHESIVE FORMULATIONS AND DEVICES FOR TRANSDERMAL DELIVERY OF FENTANYL
Silicone adhesive formulations are provided, in which fentanyl particles are suspended one or more a solvated silicone adhesives. The formulations can be used for manufacturing improved,...
|
|
|
US20090232879 |
Thyromimetics for the Treatment of Fatty Liver Diseases
The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to prodrugs of these compounds for...
|
|
|
US20090226507 |
HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS
A method is provided for increasing the permeability of skin or mucosal tissue to topically or transdermally administered pharmacologically or cosmeceutically active agents. The method involves use...
|
|
|
US20090220580 |
Percutaneous Absorption Formulation
The present invention provides a percutaneous absorption formulation including a patch having an adhesive layer disposed on a substrate and the adhesive layer contains ketotifen fumarate and...
|
|
|
US20090214625 |
DRUG DELIVERY PATCH
The site to which a patch was stuck may be identified even after the patch is removed. A patch for drug delivery includes a drug holding portion and a backing layer. The patch further includes a...
|
|
|
US20090214624 |
TOPICAL NITRIC OXIDE DONOR DEVICES AND METHODS FOR THEIR THERAPEUTIC USE
The present invention is related to topical nitric oxide delivery systems, and to using the same for mitigating or remediating various disease states The present invention is also related to using...
|
|
|
US20090208561 |
TRANSDERMAL THERAPEUTIC SYSTEM
The present invention relates to a transdermal therapeutic system for the controllable release of an active ingredient, particularly a substance promoting wound healing, to a chronic wound or for...
|
|
|
US20090196911 |
Silicone Acrylate Hybride Composition and Method Of Making Same
A silicone acrylate hybrid composition includes the reaction product of a silicon-containing pressure sensitive adhesive composition, an ethylenically unsaturated monomer, and an initiator. The...
|
|
|
US20090186072 |
Operational status for active transdermal medicament patch
An active transdermal medicament patch includes a planar substrate with a therapeutic face releasably retainable against the skin of a patient. A return electrode and a medicament matrix...
|
|
|
US20090181075 |
DROSPIRENONE CONTAINING TRANSDERMAL DRUG DELIVERY DEVICES AND METHODS OF DELIVERY THEREOF
A transdermal drug delivery device comprising an adhesive matrix, an effective amount of drospirenone, and an oligomeric adjuvant selected from an oligolactic acid, oligolactic acid derivatives, or...
|
|
|
US20090175929 |
Transdermally absorbable Donepezil Preparation
Disclosed is a donepezil-containing transdermally absorbable preparation which develops reduced adverse side effects and shows a satisfactory level of therapeutic effect. The preparation comprises...
|
|
|
US20090175928 |
Lip Plaster
The invention relates to a self-adhesive lip plaster which comprises at least one single-layered matrix and which contains at least one antiviral active medical substance for using in the event of...
|
|
|
US20090175927 |
Administration of cells and cellular extracts for rejuvenation
The invention describes methods and agents for improving cosmetic appearance, for promoting, improving or restoring health of cells and tissues, preferably skin, and more preferably, for restoring...
|
|
|
US20090169606 |
Low Flexural Strength Transdermal Tobacco Alkaloid Patch
The invention relates to a tobacco alkaloid patch for transdermal administration of a tobacco alkaloid, said patch comprising an impermeable backing ( 17 ) and a membrane ( 14 ) which defines a...
|
|
|
US20090156982 |
Transdermal treatment device and method
A treatment device for treating a medical condition comprises a composition selected for its ability to treat the medical condition, the composition being formulated for transdermal delivery. A...
|
|
|
US20090155343 |
Tamsulosin-Containing Transdermal Patch
A tamsulosin-containing transdermal patch. A transdermal patch comprising a backing-layer and an adhesive layer on the backing-layer, characterized in that the adhesive layer contains an acrylic...
|
|
|
US20090142390 |
TRANSDERMAL SYSTEMS CONTAINING MULTILAYER ADHESIVE MATRICES TO MODIFY DRUG DELIVERY
A transdermal drug-containing dosage unit comprises: a backing layer substantially impervious to the drug to be delivered transdermally; a first polymeric adhesive matrix, in contact with the...
|
|
|
US20090130190 |
Transdermal System for the Delivery of Sufentanil and Its Analogs
Methods and systems for the transdermal delivery of sufentanil and its analogs are described, from patches having a unique pharmacodynamic profile that can be used to treat persistent pain over...
|
|
|
US20090130189 |
MEANS FOR TRANSDERMAL ADMINISTRATION OF NICOTINE
Devices for transdermal administration of nicotine, which provide for basic as well as additional user activatable administration of nicotine, as well as use of such devices.
|
|
|
US20090123528 |
TRANSDERMAL DELIVERY OF BENEFICIAL SUBSTANCES EFFECTED BY A HOSTILE BIOPHYSICAL ENVIRONMENT
The present invention generally relates to the transdermal delivery of substances and, in some embodiments, to the transdermal delivery of beneficial substances by a hostile biophysical...
|
|
|
US20090123527 |
METHOD OF INDUCING TOPICAL ANESTHESIA AND TRANSDERMAL PATCH
Disclosed is a method of inducing topical anesthesia in a tissue or organ of an animal comprising providing an aqueous gel formulation comprising water, an anesthetic (e.g., lidocaine...
|
|
|
US20090110718 |
Derivatives of tiacumicin B as anti-cancer agents
New derivatives of tiacumicin B are disclosed and are presented by the general formula:
wherein R is
The use of these derivatives as a method for treating cancer or tumor is disclosed. A...
|
|
|
US20090104253 |
Hemostatic biocidal dressing
A hemostatic biocidal dressing includes pro-coagulant and biocidal agents providing a physical barrier to bleeding as well as chemical action to promote blood coagulation and thereby arrest...
|
|
|
US20090074846 |
Patch containing a medicament
A patch containing a medicament comprises a release paper oppositely lying on the surface of a patch carrier. The release paper is defined to, from right to left, a first teardown slice, a second...
|
|
|
US20090074845 |
TRANSDERMAL ACTIVE PRINCIPLE DELIVERY MEANS
A transdermal active principle delivery means comprises a skin adherent or otherwise skin-tolerant substrate applicable to a skin area affected by DNA virus, which substrate includes a composition...
|
|
|
US20090074844 |
TRENADERMAL ABSORPTION PREPARATION
The present invention relates to a blood concentration regulation type percutaneous absorption preparation, which comprises an ester form of...
|
|
|
US20090062720 |
Transdermal Methods and Systems for the Delivery of Corticosteroid Compounds
An integrated iontophoresis skin-worn patch and method for delivering a therapeutically effective amount of a corticosteroid drug compound in a systemically-safe and skin-safe manner for...
|
|
|
US20090060986 |
Transdermal delivery systems
Disclosed are bupivacaine transdermal delivery systems, and related methods.
|
|
|
US20090053290 |
TRANSDERMAL DRUG DELIVERY COMPOSITIONS AND TOPICAL COMPOSITIONS FOR APPLICATION ON THE SKIN
Transdermal delivery compositions and topical compositions for application to the skin are provided. The transdermal delivery composition includes at least two penetrants working synergistically...
|
|
|
US20090053289 |
KIT FOR THE TREATMENT OF A CORN OR CALLUS
The present invention is a kit for use by a person to apply a daily treatment of medication and therapy to remove a corn or callus from the person's skin while providing maximum comfort to the...
|
|
|
US20090047334 |
TRANSDERMAL PATCH FOR EXTENDED DELIVERY OF CALCIUM
The present invention relates to a method for delivery of calcium that avoids the problems with orally given calcium tablets. Particularly, the present invention is a transdermal patch for...
|
|
|
US20090035357 |
Method of drug delivery using a transdermal device having a phase change material
A method of drug delivery utilizes a transdermal device that contains a phase change material and a first material such as a drug, a pharmaceutical, or a medicament mixed with or disposed near the...
|
|
|
US20090017102 |
Enhancing transdermal delivery of opiod antagonists and agonistis using codrugs links to bupropion or hydroxybupropion
The present invention is directed to novel codrugs comprising bupropion or hydroxybupropion and an opioid antagonist or an opioid agonist joined together by chemical bonding. The codrugs provide a...
|
|
|
US20090010998 |
Drug-delivery patch comprising a dissolvable layer and uses thereof
The present invention provides a drug-delivery patch having at least one dissolvable layer comprising an active material and an adhesive backing or cover. The present invention also provides a...
|
|
|
US20090005745 |
Transdermal drug delivery systems for delivering anti-inflammatory drugs
Systems for delivering an anti-inflammatory drug and methods for treating osteoarthritis are provided. Such systems can comprise, in one embodiment, a transdermal patch with a sufficient amount of...
|
|
|
US20090004257 |
TRANSDERMAL ADMINISTRATION OF FENTANYL AND ANALOGS THEREOF
A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended...
|
|
|
US20090004250 |
DUAL RELEASE NICOTINE FORMULATIONS, AND SYSTEMS AND METHODS FOR THEIR USE
This invention relates generally to a method to provide habitual tobacco users with products, methods and apparatus to reduce and eventually terminate their dependence on nicotine containing...
|
|
|
US20080317832 |
TRANSDERMAL DELIVERY SYSTEM COMPRISING GLYCOPYRROLATE TO TREAT SIALORRHEA
In one aspect, the invention includes a method for treating sialorrhea, comprising the steps of identifying a patient afflicted with sialorrhea and administering a therapeutically effective amount...
|